HIPPAA Gutted Again - the Sound and Fury of Patient Privacy Laws in the U.S.

From the Health Privacy Project:
Yesterday, the U.S. Department of Justice issued a ruling that significantly weakens the enforcement provisions of the HIPAA (Health Insurance Portability and Accountability Act) Privacy Rule (see R. Pear, New York Times, 6/7/05). Under the new ruling, only covered entities (such as hospitals, doctors, and health plans)and not necessarily their employeescan be held accountable and prosecuted for criminal penalties under the Privacy Rule. This is a disturbing reversal and a stunning contradiction to the first criminal conviction under the Privacy Rule, whereby an employee of a consortium of cancer hospitals admitted to wrongful disclosure of a patients personal health information. Outside of that one criminal conviction and despite more than 13,000 complaints, the Department of Health and Human Services (HHS) has never issued a penalty for violations of the HIPAA Privacy Rule. The complaint-driven enforcement process of the Privacy Rule is already inadequate, but this ruling dramatically weakens the impact of the law and significantly limits the recourse patients have when their health information is illegally accessed, used, or disclosed.

This ruling is particularly distressing as the Bush administration
continues to press for the development of a National Health Information
Network (NHIN)with HHS Secretary Leavitt yesterday announcing the
creation of a new advisory panel to set federal standards for a national
electronic medical record (EMR) system. On the heels of the Secretarys
announcement, the administrations ruling only continues to undermine the
force of the first federal law protecting individuals sensitive health
information. Given the administrations track record and the lack of any
real commitment to ensuring that Americans personal health information
will be protected, the Health Privacy Project (HPP) is seriously
concerned that consumer and privacy advocates will not be fully
represented on the advisory panel. The public is more concerned than ever
about the privacy of their most sensitive information, especially in
light of well-publicized privacy and security breaches at major financial
and marketing firms.

Our fundamental concern is that without a strong and enforceable federal
health privacy law, patients will continue to take steps to protect
themselves from discrimination and stigma by limiting what they tell
their doctors and avoiding health care. Such privacy-protective behavior
is likely to increase if the government presses for an electronic health
network that does not adequately safeguard the privacy and security of
peoples sensitive health information.

[thanks Darby Penney]

contribute a comment

Comments have been closed for this post.

what is this?

A 'Nature Top 50' science blog by the editors, staff and friends of The American Journal of Bioethics. Science writes: "To follow the latest twists in ... science stories with social impact, dive into this Web log"

The original story behind this blog

What people are saying about blog.bioethics.net

recently on blog.bioethics.net

Caplan: New Mammogram Recommendations Accurate, but Not Right

While the data may support pushing back the timeline for routine mammograms from age 40 to 50 for women, Arthur Caplan questions the decision in... (more)

Give Me ObamaCare and Give Me Your So-Called "Death Panels." It's Surely Better Than What We Have Now.

The conservative blog, mercatornet.com, invited yours truly to be part of a debate on health reform, the controversy over so called "death panels", and my... (more)

Caplan: Swine Flu Response Isn't Even Worth Sneezing At

For all the planning, prioritizing, and head scratching done by state and federal governments for the coming H1N1 flu crisis this fall, we still have... (more)

The November Issue of AJOB Is Now Online!

With H1N1 and flu vaccines on everyone's minds, the November issue of The American Journal of Bioethics couldn't be more timely. What do people think... (more)

Q & A on What is a Blockbuster Anti-Wrinkle Cream Worth, Morally Speaking
Or How Many Fetuses Does It Take To Make a Great Cosmeceutical

Question: What is it worth to produce a blockbuster anti-wrinkle cream? Hypothetical Answer from Cosmeceutical Company: A single skin biopsy of a 14-week old voluntarily... (more)

this blog's feed

  • Subscribe
    • XML
    • Google Reader or Homepage
    • Add to My Yahoo!
    • Subscribe with Bloglines
    • Subscribe in NewsGator Online
    • Add to My AOL
    • Convert RSS to PDF
    • Add to Technorati Favorites!
    • Add to your phone
    • Get RSS Buttons

info

archives

tags